VOV.VN - Prime Minister Pham Minh Chinh has called on US healthcare giant Abbott to expand its investment and upgrade the quality of its pharmaceutical manufacturing plants in Vietnam as a way of promoting the domestic pharmaceutical industry.
At a reception in Hanoi on August 9 for Robert Ford, Abbott's Chairman of the Board and Chief Executive Officer, PM Chinh said Vietnam considers the US a leading partner in its foreign policy, and desires to strengthen the bilateral comprehensive partnership in a more practical and effective manner and on the basis of mutual respect for independence, sovereignty and territorial integrity, and political institutions of each other.
PM Chinh thanked the US government and businesses, particularly Abbott, for their support to Vietnam in the COVID-19 fight, and appreciated the group’s practical and effective contributions to national economic development as well as the joint ties.
Both sides showed their elation at the outstanding development of the Vietnam- US relations over the past time, saying the US has become Vietnam’s biggest importer, while Vietnam has been the US’ seventh largest trade partner globally and its biggest in the Association of Southeast Asian Nations (ASEAN).
The Vietnamese cabinet leader affirmed that the Vietnamese government always listens to opinions raised by enterprises, including those from the US, and offers optimal conditions for them to expand operations, especially in digital transformation, digital economy, manufacturing and processing, health care, high-tech, and high-quality personnel training.
He hailed Abbott’s introduction of cutting-edge medical technologies to the Vietnamese market, and asked firms from the US and other countries to further invest in Vietnam, helping the country in the area of nutrition.
In response, Ford applauded Vietnam’s development achievements, especially in socio-economic recovery post pandemic, as well as the nation’s open policies towards enterprises.
Vietnam boasts potential for developing clinical research and large-scale pharmaceutical production, he said, while affirming Abbott’s readiness to continue its long-term investment in the country.